Cierra N. Sharp

Cierra N. Sharp

Jun 01, 2016

Group 6 Copy 87
0

The Link Between Cancer and Fibrosis

I found an interesting article today (Link here:http://ndt.oxfordjournals.org/... ) that focuses on the relationship between cancer and fibrosis.  Cancer is driven by mutations that lead to a less differentiated cellular state accompanied by overactive proliferation, ultimately resulting in tumors and eventually metastasis.  Under normal physiological conditions, active proliferation is NECESSARY for regeneration after injury (think when you scratch yourself and subsequent wound healing).  On the other hand, fibrosis is often regarded as "putting the brakes" on proliferative processes as fibrosis is often associated with high levels of cellular senescence, or cells being arrested at some point in the cell cycle.  In this way, we can regard fibrosis and cancer as alternative processes to each other. 

This relationship between fibrosis and cancer may be evolutionary in nature.  Fibrosis may have developed as a way to combat processes leading to cancer.  And in this way, fibrosis may serve as a natural defense mechanism against cancer.     

I thought that this was an interesting idea that I have to be mindful of as I work on my project.  The aim of my project is to eventually find an anti-fibrotic agent that will protect from or reverse kidney fibrosis.  But if fibrosis is essential for stopping cancer from occurring, this may suggest that using an anti-fibrotic agent may increase the likelihood of developing a kidney-related cancer.  

I also find this relationship interesting because I've started using my cisplatin model in a lung cancer mouse model to make my model even more clinically relevant.  Even though cisplatin is a chemotherapeutic and we should see an increase in survival of these mice treated with the drug, we actually see the opposite effect.  Furthermore, we also see an exacerbated level of fibrosis in the kidney.  While we don't yet know how or why this is occurring, it's an interesting find nonetheless.  It also further supports the idea that fibrosis and cancer are related processes.

0 comments

Join the conversation!Sign In

About This Project

A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

Blast off!

Browse Other Projects on Experiment

Related Projects

Urban Pollination: sustain native bees & urban crops

Bee activity on our crop flowers is crucial to human food security, but bees are also declining around the...

Cannibalism in Giant Tyrannosaurs

This is the key question we hope to answer with this study. This project is to fund research into a skull...

Seattle HiveBio Community Lab

Thank you to everyone who has supported HiveBio thus far. As of April 17th we've reached our basic funding...

Backer Badge Funded

Add a comment